TDG · TransDigm Group INC · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-03 | Reiss Joel |
Co-Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (Direct)
7,600 options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. 11,650 options are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to achievement of annual operating performance targets each year. |
Stock Option
|
19,250 |
| 2026-11-03 | Howley W Nicholas |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | Lisman Michael |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (Direct)
These options were granted in accordance with the Employment Agreement, and are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to achievement of annual operating performance targets each year. |
Stock Option
|
30,908 |
| 2026-11-03 | MCCULLOUGH GARY E |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | Palmer Peter |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | Lisman Michael |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (Direct)
These options were granted in lieu of a cash bonus for Fiscal year 2026 in accordance with the Employment Agreement, and are eligible to vest on September 30, 2027, subject to the applicable vesting conditions. |
Stock Option
|
1,053 |
| 2026-11-03 | Murphy Patrick Joseph |
Co-Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (Direct)
5,250 options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. 20,400 options are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to achievement of annual operating performance targets each year. |
Stock Option
|
25,650 |
| 2026-11-03 | HENNESSY SEAN P |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | BARR DAVID |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | Wynne Sarah |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Direct)
4,700 options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. 10,450 options are exercisable in two equal installments on September 30, 2030, and September 30, 2031, subject to achievement of annual operating performance targets each year. |
Stock Option
|
15,150 |
| 2026-11-03 | Lisman Michael |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (Direct)
These options were granted in accordance with the Employment Agreement and are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. |
Stock Option
|
18,923 |
| 2026-11-03 | Krasik Irina Igorevna |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | Santana Michele |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | Graff Michael |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | Vadiee Armani |
GC, CCO, Secretary |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to achievement of annual operating performance targets each year. |
Stock Option
|
13,600 |
| 2026-11-03 | SMALL ROBERT J |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | CRONIN JANE M. |
Director |
Award↑
Filing footnotes — Stock Option (Direct)
These options are exercisable at 20% per year over five years beginning September 30, 2027, subject to the achievement of annual operating performance targets in each year. |
Stock Option
|
589 |
| 2026-11-03 | Lisman Michael |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (Direct)
These options were granted in lieu of a cash bonus for Fiscal year 2026 in accordance with the Second Amended and Restated Employment Agreement, dated as of October 1, 2025, between TransDigm Group Incorporated and Michael Lisman, previously disclosed as Exhibit 10.1 to the Company's Form 8-K filed with the Securities and Exchange Commission on October 1, 2025 (the 'Employment Agreement'), and became exercisable on the grant date of November 3, 2026. |
Stock Option
|
4,214 |
| 2026-11-03 | Lisman Michael |
Director, President & CEO |
Award↑
Filing footnotes — Stock Option (Direct)
These options were granted in accordance with the Employment Agreement, and are exercisable at 80% in 2027 and 20% in 2028, subject to achievement of annual operating performance targets each year. |
Stock Option
|
4,189 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,129.8000 - $1,130.7600. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
100 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,126.4800 - $1,127.4500. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
305 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,127.6400 - $1,128.5000. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
120 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,130.9100 - $1,131.7800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
130 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,133.4400 - $1,134.4150. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
317 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,116.7500 - $1,117.6800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
60 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,125.4800 - $1,126.3300. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
278 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Convert↓
|
Stock Option
|
4,100 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,123.4400 - $1,124.4100. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
306 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,128.7700 - $1,129.7600. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
150 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,115.7000 - $1,116.6700. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
50 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,134.4700 - $1,135.4500. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
495 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,124.4600 - $1,125.4400. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
600 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,113.2100 - $1,114.0300. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
100 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,120.2200 - $1,120.3500. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
30 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,118.6700 - $1,119.2000. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
100 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,111.9600 - $1,112.5700. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
20 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,121.2600 - $1,122.0700. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
60 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,114.5200 - $1,115.1300. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
100 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,135.5100 - $1,136.2400. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
438 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Convert↑
|
Common Stock
|
4,100 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,131.9200 - $1,132.8800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
210 |
| 2026-10-15 | Reiss Joel |
Co-Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1,122.4300 - $1,123.3800. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
131 |
| 2026-09-18 | MCCULLOUGH GARY E |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Common Stock
|
41 |
| 2026-09-18 | Krasik Irina Igorevna |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Common Stock
|
13 |
| 2026-09-18 | Howley W Nicholas |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Common Stock
|
126 |
| 2026-09-18 | Santana Michele |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Common Stock
|
34 |
| 2026-09-18 | SMALL ROBERT J |
Director |
Other↑
|
Common Stock
|
0 |
| 2026-09-18 | CRONIN JANE M. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Common Stock
|
34 |
| 2026-09-18 | BARR DAVID |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Common Stock
|
46 |
| 2026-09-18 | HENNESSY SEAN P |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Receipt of stock in lieu of payment of semi-annual director fee, based on fair market value in accordance with the Director Share Plan. |
Common Stock
|
46 |